Show simple item record

dc.contributor.authorSoond, S. M.
dc.contributor.authorKozhevnikova, M. V.
dc.contributor.authorSavvateeva, L. V.
dc.contributor.authorTownsend, Paul A
dc.contributor.authorZamyatnin, A. A., Jr.
dc.date.accessioned2021-05-18T08:48:18Z
dc.date.available2021-05-18T08:48:18Z
dc.date.issued2021en
dc.identifier.citationSoond SM, Kozhevnikova MV, Savvateeva LV, Townsend PA, Zamyatnin AA Jr. Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis. IJMS. 2021 Apr 28;22(9):4669.en
dc.identifier.pmid33925117en
dc.identifier.doi10.3390/ijms22094669en
dc.identifier.urihttp://hdl.handle.net/10541/624057
dc.description.abstractTaken with the growing importance of cathepsin-mediated substrate proteolysis in tumor biology and progression, the focus and emphasis placed on therapeutic design and development is coming into fruition. Underpinning this approach is the invariable progression from the direction of fully characterizing cathepsin protease members and their substrate targets, towards targeting such an interaction with tangible therapeutics. The two groups of such substrates that have gained much attention over the years are the pro- and anti- apoptotic protein intermediates from the extrinsic and intrinsic signaling arms of the apoptosis pathway. As proteins that are central to determining cellular fate, some of them present themselves as very favorable candidates for therapeutic targeting. However, considering that both anti- and pro- apoptotic signaling intermediates have been reported to be downstream substrates for certain activated cathepsin proteases, therapeutic targeting approaches based on greater selectivity do need to be given greater consideration. Herein, we review the relationships shared by the cathepsin proteases and the Bcl-2 homology domain proteins, in the context of how the topical approach of adopting 'BH3-mimetics' can be explored further in modulating the relationship between the anti- and pro- apoptotic signaling intermediates from the intrinsic apoptosis pathway and their upstream cathepsin protease regulators. Based on this, we highlight important future considerations for improved therapeutic design.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.3390/ijms22094669en
dc.titleIntrinsically connected: therapeutically targeting the cathepsin proteases and the Bcl-2 family of protein substrates as co-regulators of apoptosisen
dc.typeArticleen
dc.contributor.departmentInstitute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya str. 8-2, 119991 Moscow, Russien
dc.identifier.journalInternational Journal of Molecular Sciencesen
dc.description.noteen
refterms.dateFOA2021-05-19T09:10:09Z


Files in this item

Thumbnail
Name:
33925117.pdf
Size:
11.80Mb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record